Clinical Trials Browser

Completed × OTHER × IRX 2 × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Neoplasm Metastasis, Recurrence

NCT03918499 2023-03-23

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

Phase 1/2 Completed

9 enrolled 9 charts

Gastrointestinal

Clinical Stage IV Gastric Cancer AJCC v8

Clinical Trials

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer